C-suite leaders race to keep up with the rapid pace of AI before competitors take the lead [Fortune]
Vor Biopharma Inc. (VOR)
Company Research
Source: Fortune
A report by KPMG International out this morning finds that 81% of U.S. executives surveyed said it's difficult to keep up with the rapid pace of technological change—and they worry about lagging behind other companies. The top concern is market competition (73%). Meanwhile, trust in new technologies (70%), and regulatory challenges (69%) round out the top three concerns, according to the report And more than half (56%) of respondents said they often feel they don't have the budget to keep up with the fast pace. CFOs can encourage prioritizing technology investments that may have “a direct impact on revenue generation and yield significant ROI,” Sanjay Sehgal, head of markets for KPMG Advisory, told me. Finance chiefs can also urge the board and the organization to look critically at what is happening in their industry and the moves competitors are making, he said. The findings are based on a survey of 400 U.S.-based tech leaders, like chief digital officers, CIOs, CISOs, chief AI
Show less
Read more
Impact Snapshot
Event Time:
VOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VOR alerts
High impacting Vor Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
VOR
News
- Vor Bio to Participate in the Stifel 2024 Healthcare ConferenceGlobeNewswire
- Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.MarketBeat
- Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.MarketBeat
- Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company UpdateGlobeNewswire
- Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial OfficerGlobeNewswire
VOR
Earnings
- 11/7/24 - In-Line
VOR
Sec Filings
- 11/14/24 - Form SC
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- VOR's page on the SEC website